MAP2K7 and glioblastoma: Moreover, very little is known about Eph receptor signaling in glioblastoma (GBM) despite that EphA2 overexpression drives cell proliferation via MEK/ERK in GBM (26–28) and cell invasion via AKT signaling in glioma stem cells (29).